American Research & Management Co. Raises Holdings in Colgate-Palmolive (CL)

American Research & Management Co. grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 872.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,961 shares of the company’s stock after purchasing an additional 4,451 shares during the period. American Research & Management Co.’s holdings in Colgate-Palmolive were worth $340,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CL. Capital Financial Planning LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth about $27,000. Parisi Gray Wealth Management grew its position in Colgate-Palmolive by 365.3% in the 4th quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after buying an additional 369 shares in the last quarter. Timber Creek Capital Management LLC grew its position in Colgate-Palmolive by 247.1% in the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after buying an additional 336 shares in the last quarter. Portfolio Solutions LLC bought a new position in Colgate-Palmolive in the 4th quarter valued at about $30,000. Finally, WP Advisors LLC bought a new position in Colgate-Palmolive in the 1st quarter valued at about $34,000. 76.27% of the stock is currently owned by institutional investors.

NYSE CL traded up $0.19 on Tuesday, reaching $68.90. The company’s stock had a trading volume of 166,605 shares, compared to its average volume of 3,025,804. Colgate-Palmolive has a twelve month low of $57.41 and a twelve month high of $72.61. The company has a current ratio of 1.14, a quick ratio of 0.76 and a debt-to-equity ratio of 32.25. The company has a market capitalization of $59.13 billion, a price-to-earnings ratio of 23.19, a PEG ratio of 4.45 and a beta of 0.79.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 25th. The company reported $0.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The company had revenue of $3.81 billion during the quarter, compared to the consensus estimate of $3.78 billion. During the same period in the prior year, the company earned $0.75 EPS. Colgate-Palmolive’s revenue was down 2.1% on a year-over-year basis. As a group, research analysts predict that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Wednesday, April 17th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a yield of 2.50%. Colgate-Palmolive’s dividend payout ratio is currently 56.57%.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “sell” rating in a research report on Monday. UBS Group increased their target price on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, March 29th. Citigroup set a $68.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Tuesday, March 19th. BNP Paribas upgraded shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their target price for the company from $56.00 to $67.00 in a research report on Monday, February 11th. Finally, Credit Suisse Group assumed coverage on shares of Colgate-Palmolive in a research report on Wednesday, March 6th. They issued an “underperform” rating for the company. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and a consensus price target of $65.73.

In other Colgate-Palmolive news, CEO Ian M. Cook sold 22,634 shares of the company’s stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the completion of the sale, the chief executive officer now directly owns 1,162,793 shares of the company’s stock, valued at $77,104,803.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Ian M. Cook sold 17,750 shares of the company’s stock in a transaction dated Friday, March 29th. The shares were sold at an average price of $67.37, for a total transaction of $1,195,817.50. Following the sale, the chief executive officer now directly owns 1,130,793 shares of the company’s stock, valued at $76,181,524.41. The disclosure for this sale can be found here. Insiders have sold 85,450 shares of company stock valued at $5,682,621 over the last ninety days. Insiders own 1.14% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.com-unik.info/2019/04/16/american-research-management-co-raises-holdings-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Further Reading: Strangles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit